S1H is a helical peptide designed to emulate specific protein-protein interaction surfaces. Hydrophobic faces stabilize helix formation, while charged residues tune solubility. Researchers evaluate its stability, folding, and binding behavior. Applications include helix-mimetic design, PPI inhibition studies, and structural biophysics.
CAT No: R2826
S1H, also known as Sialyl Lewis X Hexasaccharide, is a synthetic carbohydrate compound that plays a pivotal role in glycoscience research due to its unique structural and functional properties. As a member of the sialylated oligosaccharide family, S1H is composed of a specific arrangement of monosaccharide units, including sialic acid, fucose, galactose, and N-acetylglucosamine, which are linked in a manner that mimics naturally occurring cell-surface glycans. Its intricate structure makes it a valuable tool for probing carbohydrate-mediated interactions, particularly those involved in cell recognition and adhesion processes. Researchers often rely on S1H to elucidate the mechanisms underlying cellular communication, immune response modulation, and pathogen-host interactions, as its configuration closely resembles biologically relevant glycoconjugates. The compound's stability and defined composition further enhance its utility across a wide spectrum of scientific applications, supporting both fundamental research and the development of innovative biochemical assays.
Cell Adhesion Studies: In the realm of cell biology, Sialyl Lewis X Hexasaccharide is extensively employed to investigate the mechanisms of cell adhesion, particularly those mediated by selectins. Selectins are a family of cell adhesion molecules that recognize specific carbohydrate motifs, with S1H serving as a model ligand for these interactions. By incorporating S1H into in vitro assays, researchers can dissect the binding affinities and specificities between selectins and their glycan ligands, shedding light on the molecular events that govern leukocyte trafficking and tissue homing. This application is crucial for understanding how cells navigate complex biological environments, and it provides foundational knowledge for the design of targeted interventions in inflammatory and immune-related processes.
Glycan-Protein Interaction Analysis: S1H is a key reagent in the study of glycan-protein interactions, which are central to many physiological and pathological phenomena. By immobilizing S1H on microarrays or biosensor surfaces, scientists can systematically screen for proteins, such as lectins or antibodies, that specifically recognize the sialylated Lewis X epitope. This approach enables high-throughput profiling of glycan-binding proteins, facilitating the discovery of novel biomarkers and therapeutic targets. The ability to map these interactions with precision enhances our understanding of cellular signaling pathways and the role of glycosylation in modulating protein function.
Pathogen Recognition Research: The unique structure of S1H makes it an essential tool for studying pathogen recognition and host-pathogen interactions. Many viruses, bacteria, and parasites exploit sialylated glycans on host cell surfaces to initiate infection. By using S1H as a surrogate for these natural glycans, researchers can model and analyze the initial steps of pathogen attachment and entry. Insights gained from such studies inform the development of strategies to block pathogen adhesion, contributing to the broader field of infectious disease research and prevention.
Glycobiology Tool Development: As a well-characterized oligosaccharide, S1H is integral to the creation of novel analytical tools and platforms in glycobiology. It is often used as a reference standard or calibration compound in various analytical techniques, including mass spectrometry, high-performance liquid chromatography, and glycan microarrays. These applications enable the accurate detection, quantification, and characterization of complex glycans in biological samples, supporting advancements in glycomics and systems biology.
Immunological Research: In immunological studies, S1H is utilized to explore the interplay between glycan structures and immune cell function. Its presence on synthetic or natural carriers allows for the investigation of how sialylated Lewis X motifs influence the recognition and activation of immune cells, such as neutrophils and dendritic cells. This line of research provides valuable insights into the modulation of immune responses and the potential for glycan-based immunomodulatory agents. By leveraging S1H in these diverse applications, scientists are able to deepen their understanding of carbohydrate-mediated biological processes and drive innovation across multiple disciplines within the life sciences.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More